Compare SGP & BFST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SGP | BFST |
|---|---|---|
| Founded | 2019 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 932.9M | 877.1M |
| IPO Year | N/A | 2014 |
| Metric | SGP | BFST |
|---|---|---|
| Price | $20.78 | $27.87 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | ★ $45.00 | $32.75 |
| AVG Volume (30 Days) | 51.9K | ★ 141.8K |
| Earning Date | 05-15-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 2.23% |
| EPS Growth | N/A | ★ 23.45 |
| EPS | N/A | ★ 0.68 |
| Revenue | N/A | ★ $10,704,000.00 |
| Revenue This Year | N/A | $22.71 |
| Revenue Next Year | N/A | $5.02 |
| P/E Ratio | ★ N/A | $41.16 |
| Revenue Growth | N/A | ★ 1.20 |
| 52 Week Low | $20.15 | $22.56 |
| 52 Week High | $30.56 | $30.32 |
| Indicator | SGP | BFST |
|---|---|---|
| Relative Strength Index (RSI) | 36.44 | 55.01 |
| Support Level | N/A | $26.73 |
| Resistance Level | $26.29 | $28.74 |
| Average True Range (ATR) | 1.54 | 0.53 |
| MACD | -0.28 | 0.08 |
| Stochastic Oscillator | 2.59 | 75.72 |
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.
Business First Bancshares Inc is a bank holding company. The company's services include personal and commercial banking, treasury management, and wealth solutions. It provides a range of financial services to small-to-midsized businesses and professionals. The company generates the majority of its revenues from interest income on loans, customer service and loan fees, and interest income from securities.